Immucell (ICCC) EBT Growth (3y) (2013 - 2026)
Powered by 
Analysis
Immucell (ICCC) EBT Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 13.42% |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | -0.23% |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | 39.40% |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | 14.68% |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | 49.85% |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -350.08% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 49.85% |
| Dec 31, 2025 | -19.53% |
| Sep 30, 2025 | 40.77% |
| Jun 30, 2025 | 39.89% |
| Mar 31, 2025 | 41.22% |
| Dec 31, 2024 | 90.54% |
| Sep 30, 2024 | -86.58% |
| Jun 30, 2024 | -134.19% |
| Mar 31, 2024 | 0.36% |
| Dec 31, 2023 | -99.07% |
| Sep 30, 2023 | -42.78% |
| Jun 30, 2023 | -21.64% |
| Mar 31, 2023 | -156.62% |
| Dec 31, 2022 | -74.41% |
| Sep 30, 2022 | -9.57% |
| Jun 30, 2022 | -3.74% |
| Mar 31, 2022 | 49.62% |
| Dec 31, 2021 | 27.50% |
| Sep 30, 2021 | 37.68% |
| Jun 30, 2021 | 35.28% |